On June 22, 2020 Grey Wolf Therapeutics reported that it will present an e-poster and accompanying audio description at AACR (Free AACR Whitepaper) 2020 (Virtual Annual Meeting II) (Press release, Grey Wolf Therapeutics, JUN 22, 2020, View Source [SID1234561270]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The company has generated potent oral ERAP1 inhibitors that modify the immunopeptidome in vivo and represent novel immunotherapy agents.

Visit the American Association for Cancer Research (AACR) (Free AACR Whitepaper) website and head to e-poster 5551 for more information. The virtual event will run from June 22 – June 24.